Arecor Therapeutics plc (LON:AREC – Get Free Report) shares shot up 0.4% during mid-day trading on Thursday . The company traded as high as GBX 74.30 ($0.96) and last traded at GBX 74.30 ($0.96). 3,000 shares traded hands during mid-day trading, a decline of 79% from the average session volume of 14,507 shares. The stock had previously closed at GBX 74 ($0.96).
Arecor Therapeutics Stock Performance
The company has a quick ratio of 6.24, a current ratio of 1.37 and a debt-to-equity ratio of 5.51. The firm has a market cap of £28.13 million, a P/E ratio of -265.36 and a beta of -0.18. The business has a fifty day simple moving average of GBX 75.96 and a 200-day simple moving average of GBX 107.12.
About Arecor Therapeutics
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Read More
- Five stocks we like better than Arecor Therapeutics
- Market Cap Calculator: How to Calculate Market Cap
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- 3 REITs to Buy and Hold for the Long Term
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Using the MarketBeat Stock Split Calculator
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
